Related Experiment Video
Updated: Mar 26, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Parechovirus Encephalitis and Neurodevelopmental Outcomes
Philip N Britton1, Russell C Dale2, Michael D Nissen3
1Sydney Medical School, Sydney, Australia; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia; Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, Australia; philip.britton@health.nsw.gov.au.
Insights
Human parechovirus (HPeV) encephalitis in infants often presents with seizures and MRI abnormalities. This condition can lead to significant neurodevelopmental issues, including cerebral palsy, even with initially reassuring outcomes.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neuroscience
Background:
- Human parechovirus (HPeV) is an emerging cause of encephalitis in infants.
- Early identification and understanding of clinical features are crucial for managing HPeV encephalitis.
- The Australian Childhood Encephalitis (ACE) study provides a platform for investigating encephalitis cases.
Purpose of the Study:
- To describe the clinical characteristics of HPeV encephalitis in infants.
- To evaluate the short-term and long-term outcomes of HPeV encephalitis.
- To assess the utility of diagnostic tools in identifying HPeV encephalitis.
Main Methods:
- Prospective identification of infants with suspected encephalitis in 5 hospitals.
- Comprehensive data collection including demographics, clinical presentation, laboratory results, and imaging.
- Neurodevelopmental assessment at 12 months post-discharge using the Ages and Stages Questionnaire (ASQ).
Main Results:
- Thirteen cases of suspected HPeV encephalitis were identified; 9 confirmed.
- Confirmed cases were predominantly young, female infants with seizures and white matter diffusion restriction on MRI.
- While 3/9 showed sequelae at discharge, 5/8 infants had neurodevelopmental sequelae at 12 months, including cerebral palsy and visual impairment.
Conclusions:
- HPeV encephalitis in infants presents with specific clinical and imaging findings.
- Cranial ultrasound has limited sensitivity for detecting HPeV encephalitis.
- HPeV encephalitis is associated with significant neurodevelopmental sequelae, highlighting the need for specific diagnostic testing to avoid missed diagnoses.
Objective:
We aimed to describe the clinical features and outcome of human parechovirus (HPeV) encephalitis cases identified by the Australian Childhood Encephalitis (ACE) study.
Methods:
Infants with suspected encephalitis were prospectively identified in 5 hospitals through the (ACE) study. Cases of confirmed HPeV infection had comprehensive demographic, clinical, laboratory, imaging, and outcome at discharge data reviewed by an expert panel and were categorized by using predetermined case definitions. Twelve months after discharge, neurodevelopment was assessed by using the Ages and Stages Questionnaire (ASQ).
Results:
We identified thirteen cases of suspected encephalitis with HPeV infection between May 2013 and December 2014. Nine infants had confirmed encephalitis; median age was 13 days, including a twin pair. All had HPeV detected in cerebrospinal fluid with absent pleocytosis. Most were girls (7), admitted to ICU (8), and had seizures (8). Many were born preterm (5). Seven patients had white matter diffusion restriction on MRI; 3 with normal cranial ultrasounds. At discharge, 3 of 9 were assessed to have sequelae; however, at 12 months' follow-up, by using the ASQ, 5 of 8 infants showed neurodevelopmental sequelae: 3 severe (2 cerebral palsy, 1 central visual impairment). A further 2 showed concern in gross motor development.
Conclusions:
Children with HPeV encephalitis were predominantly young, female infants with seizures and diffusion restriction on MRI. Cranial ultrasound is inadequately sensitive. HPeV encephalitis is associated with neurodevelopmental sequelae despite reassuring short-term outcomes. Given the absent cerebrospinal fluid pleocytosis and need for specific testing, HPeV could be missed as a cause of neonatal encephalopathy and subsequent cerebral palsy.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014
Related Concept Videos
Arboviral Encephalitis
Viral Meningitis
Teratogenicity
Cytomegalovirus Disease